Closing the year with recovered order intake and continued profitability Fourth quarter 2024Order intake increased 13 percent to MSEK 167.5 (148.5). 13 percent growth also at constant exchange rates.R ...

Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...